Search

Search Results
Results 1031 - 1040 of 1093 for Diabetes Type II
  • Drug - 7 Feb 2023
    Consumer Medicine Information (CMI) about DuoCover intended for persons living in Australia.
  • Drug - 7 Feb 2023
    Consumer Medicine Information (CMI) about Clopidogrel Winthrop Plus Aspirin intended for persons living in Australia.
  • Drug - 7 Feb 2023
    Consumer Medicine Information (CMI) about APX-Clopidogrel/Aspirin 75/100 intended for persons living in Australia.
  • Health - 30 Dec 2022
    The vitreous body is a round body of gel-like substance which fills the posterior chamber of the eye and aids in keeping the eyeball round. Within the gel are numerous fine strands which run to the...
  • Drug - 1 Nov 2022
    Consumer Medicine Information (CMI) about Co-Diovan (Valsartan/hydrochlorothiazide) intended for persons living in Australia.
  • Drug - 26 Oct 2022
    Consumer Medicine Information (CMI) about Iptam (sumatriptan) intended for persons living in Australia.
  • White Paper - 12 Sep 2022
    There are different solutions for cell and gene therapy -such as ultra-low and cryogenic storage- that are considered potential sources of treatments for chronic diseases.
  • Health - 7 Sep 2022
    Tennis elbow is a repetitive stress syndrome that arises from overuse of the forearm extensor muscles. Also called lateral epicondylitis, this often occurs because of repetitive activity that involves...
  • Drug - 2 Sep 2022
    Consumer Medicine Information (CMI) about Accupril intended for persons living in Australia.
  • Drug - 2 Aug 2022
    Consumer Medicine Information (CMI) about Reaptan (Perindopril/amlodipine [pronounced per-in-do-pril/ am-load-i-peen]) intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.